Status:
COMPLETED
Retrospective Evaluation of Cellulite of Laxity Treatment Using Body Tite
Lead Sponsor:
InMode MD Ltd.
Conditions:
Cellulite
Eligibility:
FEMALE
18+ years
Brief Summary
Retrospective Evaluation of Cellulite of Laxity Treatment Using Body Tite
Detailed Description
The purpose of this preliminary report is to retrospectively evaluate this novel treatment approach to improve the appearance of cellulite on the thighs and buttocks by tightening the SFS using RFAL.
Eligibility Criteria
Inclusion
- age ≥ 18years of age at the time of procedure
- patients with localized lipodystrophy in the medial or lateral thigh, and visible cellulite of laxity in the lower extremity or buttocks
- BodyTite treatments performed from January 2018 - May 2019 for Cellulite indication
Exclusion
- active infection, collagen disorders, immunocompromised state, medications that mitigate inflammatory response, and propensity for keloid/hypertrophic scaring. o BodyTite treatments performed from March 2018 - May 2019 for lipodystrophy and cellulite of laxity
Key Trial Info
Start Date :
May 5 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 30 2022
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04419454
Start Date
May 5 2020
End Date
July 30 2022
Last Update
August 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. Mark Peters
Germantown, Tennessee, United States, 38138